The wearable healthcare devices market will be worth nearly $76bn by 2030, representing a 10.9% CAGR, according to Markets & Markets.

The global market was valued at $41.07bn in 2024, and set for $45.29bn in 2025 and is projected to advance at a CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of $75.98bn.

Market growth is driven by rising health awareness, a shift towards preventive care and the increasing prevalence of chronic conditions in aging populations. Advancements in wearable technologies – including AI-enabled analytics, real-time monitoring and integration with electronic health records – have expanded the scope of these devices from fitness tracking to clinical-grade diagnostics and therapeutic support.

Additionally, growing public and private investments, widespread smartphone penetration, improved connectivity, and the preference for wireless monitoring in home and clinical settings are contributing to market expansion. The adoption of AI and the rollout of 5G are expected to accelerate innovation. However, problems such as the lack of regulatory standardisation, concerns regarding data security and limitations in clinical accuracy may restrain growth.

By product, the market is segmented into trackers, smartwatches, patches and smart clothing. In 2024, smartwatches emerged as the fastest-growing product segment, driven by their expanding range of health-focused features, seamless integration with digital ecosystems, and increasing user demand for multifunctional and accessible health monitoring. These devices are widely used to track vital health parameters such as heart rate, blood oxygen levels and sleep patterns, while also supporting fitness and wellness goals.

Ongoing innovations in sensor technologies, AI-enabled health insights and real-time data analytics have enhanced the appeal of smartwatches for consumers and healthcare professionals. The rising global adoption of smartphones, improved mobile connectivity and a growing emphasis on preventive healthcare are further accelerating their growth.

While trackers and patches continue to find relevance in targeted applications such as fitness tracking and chronic disease monitoring, and smart clothing gains traction in niche areas such as sports and rehabilitation, smartwatches remain the most dynamic and rapidly advancing segment in the wearable healthcare landscape due to their versatility, convenience and strong consumer engagement.

In 2024, consumer-grade wearable healthcare devices captured the largest market share, primarily due to the widespread adoption of smartphones, advancements in sensor miniaturisation and their seamless integration with mobile health applications. These devices – such as smartwatches, fitness trackers, wristbands and smart clothing – are easily accessible to the general public without the need for a prescription and are widely used in fitness, wellness and lifestyle management. While they often include features such as heart rate monitoring, ECG and sleep tracking, consumer-grade devices are primarily intended for general wellness and do not meet the stringent clinical accuracy or regulatory standards required for medical diagnosis or treatment.

Some devices, such as the Apple Watch, have obtained regulatory approvals for specific features, but their primary market positioning remains consumer focused. Their ability to monitor a broad range of physiological parameters, combined with user-friendly features such as Bluetooth connectivity, GPS and smartphone sync, has made them especially popular among tech-savvy users and aging populations seeking convenient, non-invasive health tools.

In 2024, North America held the largest share of the global market, driven by its advanced healthcare infrastructure, high smartphone penetration and strong emphasis on digital health adoption. The region benefits from rising consumer awareness, growing demand for remote patient monitoring, and increasing incidence of chronic conditions such as diabetes, obesity and cardiovascular diseases.

According to Pew Research (www.pewresearch.org) in 2024, a significant portion of Americans own smartphones and actively use wearable health-tracking devices, creating a favourable environment for market expansion. The continued rise in healthcare costs – CMS reported a 7% increase in national health spending in 2023 to $4.8tn, or 17.6% of GDP – has further propelled the shift towards cost-effective, home-based care models supported by wearables. Moreover, supportive government initiatives such as Medicare and Medicaid reimbursements for remote patient monitoring have accelerated adoption.

Prominent players in the wearable healthcare devices market are Apple (USA), Samsung (South Korea), Abbott (USA), DexCom (USA), Fitbit (USA), Philips (Netherlands), Omron (Japan), Garmin (Switzerland), GE HealthCare (USA), Masimo (USA), Boston Scientific (USA), Biotricity (USA), iRhythm Technologies (USA) and Contec (China).

Download a PDF brochure at www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973, request sample pages at www.marketsandmarkets.com/requestsampleNew.asp?id=81753973 or read more at www.marketsandmarkets.com/Market-Reports/wearable-medical-device-market-81753973.html.